Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$308M+2.4% YoY

Gross Profit

$50M16.3% margin

Operating Income

$21M6.8% margin

Net Income

$6M1.9% margin

EPS (Diluted)

$0.11

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$63M

Free Cash Flow

$56M

Stock-Based Comp.

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.5B

Stockholders' Equity

$166M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$308M	$301M	+2.4%
Gross Profit	$50M	$45M	+11.2%
Operating Income	$21M	$24M	-12.1%
Net Income	$6M	$10M	-42.7%

Revenue Segments

Health Care, Patient Service

$271M47%

Commercial Insurance1

$172M30%

Medicare1

$63M11%

Capitation Arrangements

$37M6%

Health Care, Patient Service Other

$8M1%

Workers' Compensation/Personal Injury1

$8M1%

Health Care, Other

$8M1%

Medicaid1

$8M1%

Health Care, Management Service

$3M0%